# Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires

> **NCT03152773** · NA · SUSPENDED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 22 (actual)

## Conditions studied

- Pulmonary Artery Hypertension
- Congenital Heart Disease
- Structural Heart Disease

## Interventions

- **PROCEDURE:** MRI Heart guidewire catheterization

## Key facts

- **NCT ID:** NCT03152773
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2017-08-02
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** The enrollment has been on hold since 2022 because the MRI scanner aging has made it inadequate for human catheter procedures.
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03152773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03152773, "Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03152773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*